Literature DB >> 526435

Oncofoetal antigen I: a target for immune cytolysis of human cancer.

N Sidell, R F Irie, D L Morton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526435      PMCID： PMC2010124          DOI： 10.1038/bjc.1979.291

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Modulation of fetal antigen(s) in mouse leukemia cells.

Authors:  J R Ortaldo; C C Ting; R B Herberman
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

2.  Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.

Authors:  E T Bloom
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  Clinical and immunological significance of human melanoma cytotoxic antibody.

Authors:  A J Bodurtha; D O Chee; J F Laucius; M J Mastrangelo; R T Prehn
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

4.  Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase.

Authors:  W A Tompkins; P B Seth; D M Yip; J L Palmer; S R Gee; W E Rawls
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

5.  Serological reactivity in cancer patients to human and mouse fetal liver cells.

Authors:  F A Salinas; K M Sheikh; S B Chandor
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

6.  Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.

Authors:  R F Irie; A E Giuliano; D L Morton
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

7.  Cross-reacting antigens in chemically induced sarcomas are fetal determinants.

Authors:  G A Parker; S A Rosenberg
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

8.  Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma.

Authors:  M A Pellegrino; S Ferrone; R A Reisfeld; R F Irie; S H Golub
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

9.  Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.

Authors:  B S Joseph; M B Oldstone
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307
  9 in total
  4 in total

1.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

2.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

Authors:  L D Cahan; R F Irie; R Singh; A Cassidenti; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine.

Authors:  D M Euhus; R K Gupta; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  In vitro production of human antibody to a tumour-associated foetal antigen.

Authors:  R F Irie; P C Jones; D L Morton; N Sidell
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.